Identification of necroptosis-related lncRNAs for prognosis prediction and screening of potential drugs in patients with colorectal cancer

Figure 8 Investigation of the tumor microenvironment. A: Comparison of ESTIMATE scores between the low- and high-risk groups; B: Comparison of immune scores between the low- and high-risk groups; C: Comparison of stomal scores between the low- and high-risk groups; D: Comparison of tumor purity between the low- and high-risk groups; E: Heatmap of immune cell infiltration showing that more immune cells were associated with the high-risk group on different platforms; F to K: More significantly reduced numbers of antitumor immune cells in the tumor microenvironment (TME) in the high-risk group; L to O: More significantly increased numbers of protumor immune cells in the TME in the high-risk group; P: Differences in the expression of 11 checkpoint molecules between the high- and low-risk groups. ^aP < 0.01, ^bP < 0.05, ^cP < 0.001. CD: Cluster of differentiation.